Elisa Teti e Alessandro Raffaelli, “Pharmaceutical sector & covid-19: the Italian measures to face the health emergency situation and the cooperation among competitors” ”, in e-Competitions Special Issue: Pharma & Covid-19 an overview of EU and national case law, Concurrences, 2020;

Enrico Adriano Raffaelli - “Biosimilars: considerations in light of the Italian legal framework”, in Gabi Journal, vol. 8, n. 1, 2019;

Enrico Adriano Raffaelli - “Regulation and Antitrust in the Pharmaceutical Field”, in Frédéric Jenny, Standing Up for Convergence and Relevance in Antitrust, Liber Amicorum, Volume I, Nicolas Charbit - Sonia Ahmad Editors, 2019;

Enrico Adriano Raffaelli - “Competition Law and IP rights in the pharmaceutical sector between technological development, consumer protection and Health Care costs: the Italian experience”, in “The Interplay between Competition Law and Intellectual Property - An international perspective”, Gabriella Muscolo e Marina Tavassi, 2019.

Enrico Adriano Raffaelli – Fausto Massimino - “Reference Biological Medicines (‘Originators’) and ‘Biosimilars’: Competition and Patient Protection, in Rivista Italiana di Antitrust, Vol 4, N. 2, 2017.

Elisa Teti e Ottavia Raffaelli - “Antitrust in Pharmaceutical Markets”, Italy, in “Antitrust in Pharmaceutical Markets & Geographical Rules of Origin”, LIDC, curato da Pierre Kobel, Pranvera Kellezi, Bruce Kilpatrick, Springer, 2017.

Enrico Adriano Raffaelli e Elisa Teti - “Co-marketing and Co-promotion Agreements” in “Competition and Patent Law in the Pharmaceutical Sector: An International Perspective”, Giovanni Pitruzzella e Gabriella Muscolo, Kluwer Law International B.V., 2016.

Enrico Adriano RaffaelliIntervista su quotidianosanita.it